UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immediate cooling does not prevent the ex vivo hydrolysis of L-asparagine by asparaginase

Therapeutic drug monitoring, 2014-08, Vol.36 (4), p.549-552

2014

Volltextzugriff (PDF)

Trabectedin therapy for sarcomas

Current opinion in oncology, 2010-07, Vol.22 (4), p.342-346

2010

Volltextzugriff (PDF)

Trabectedin for the treatment of breast cancer

Expert opinion on investigational drugs, 2016-01, Vol.25 (1), p.105-115

2016

Volltextzugriff (PDF)

Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation

Neoplasia (New York, N.Y.), 2001-01, Vol.3 (1), p.10-16

2001

Volltextzugriff (PDF)

PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel Carriers

Molecular pharmaceutics, 2016-01, Vol.13 (1), p.40-46

2016

Volltextzugriff (PDF)

Abstract 1284: Lurbinectedin reduces tumor-associated macrophages and the production of inflammatory cytokines, chemokines, and angiogenic factors in preclinical models

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1284-1284

2016

Volltextzugriff (PDF)

Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft

Anti-cancer drugs, 2005-09, Vol.16 (8), p.811-815

2005

Volltextzugriff (PDF)

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis

BMC cancer, 2017-05, Vol.17 (1), p.366-366, Article 366

2017

Volltextzugriff (PDF)

The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism

Biochemical pharmacology, 2007-03, Vol.73 (5), p.643-655

2007

Volltextzugriff (PDF)

Influence of O6-methylguanine on DNA damage and cytotoxicity of temozoiomide in L1210 mouse leukemia sensitive and resistant to chloroethylnitrosoureas

Anti-cancer drugs, 1992-08, Vol.3 (4), p.401-406

1992

Volltextzugriff (PDF)

Apoptosis Biochemical events and relevance to cancer chemotherapy

FEBS Letters, 1992-07, Vol.307 (1), p.122-127

1992

Volltextzugriff (PDF)

Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti‐cancer agents

International journal of cancer, 1996-06, Vol.66 (6), p.779-783

1996

Volltextzugriff (PDF)

p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel

Cancer research (Chicago, Ill.), 1997-03, Vol.57 (5), p.870-874

1997

Volltextzugriff (PDF)

Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis

The Journal of pharmacology and experimental therapeutics, 1997-06, Vol.281 (3), p.1226

1997

Volltextzugriff (PDF)

Decreased cytotoxic effects of doxorubicin in a human ovarian cancer‐cell line expressing wild‐type p53 and WAF1/CIP1 genes

International journal of cancer, 1995-05, Vol.61 (3), p.397-401

1995

Volltextzugriff (PDF)

DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin

Nucleic acids research, 1995-01, Vol.23 (1), p.81-87

1995

Volltextzugriff (PDF)

Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription

Nucleic acids research, 1995-05, Vol.23 (10), p.1657-1663

1995

Volltextzugriff (PDF)

Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53

Nucleic acids research, 1994-03, Vol.22 (6), p.1012-1017

1994

Volltextzugriff (PDF)

DNA-minor-groove alkylators, a new class of anticancer agents

Annals of oncology, 1994-12, Vol.5 (10), p.877-878

D'Incalci, M

1994

Volltextzugriff (PDF)

Selective DNA interaction of the novel distamycin derivative FCE 24517

Cancer research (Chicago, Ill.), 1991, Vol.51 (1), p.199-204

1991

Volltextzugriff (PDF)

Clinical pharmacokinetics of altretamine

Clinical pharmacokinetics, 1995-06, Vol.28 (6), p.439-448

1995

Volltextzugriff (PDF)

Importance of the DNA repair enzyme O 6-alkyl guanine alkyltransferase (AT) in cancer chemotherapy

Cancer treatment reviews, 1988-12, Vol.15 (4), p.279-292

1988

Volltextzugriff (PDF)

New anticancer agents. state of the art and perspectives

Pharmacological research, 1992-09, Vol.26, p.223-223

DINCALCI, M

1992

Volltextzugriff (PDF)

Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase

Nucleic acids research, 1991-06, Vol.19 (11), p.2929-2933

1991

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(75)
Humans
(50)
Oncology
(46)
Biological And Medical Sciences
(43)
Medical Sciences
(38)
Pharmacology. Drug Treatments
(36)
Animals
(30)
Antineoplastic Agents
(30)
Female
(29)
Pharmacology & Pharmacy
(27)
Mice
(23)
Antineoplastic Agents - Pharmacology
(17)
Biochemistry & Molecular Biology
(17)
Male
(17)
Dna Damage
(16)
General Aspects
(16)
Adult
(15)
Middle Aged
(14)
Chemotherapy
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immediate cooling does not prevent the ex vivo hydrolysis of L-asparagine by asparaginase

Trabectedin therapy for sarcomas

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

Trabectedin for the treatment of breast cancer

Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation

PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel Carriers

Abstract 1284: Lurbinectedin reduces tumor-associated macrophages and the production of inflammatory cytokines, chemokines, and angiogenic factors in preclinical models

Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis

The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism

Influence of O6-methylguanine on DNA damage and cytotoxicity of temozoiomide in L1210 mouse leukemia sensitive and resistant to chloroethylnitrosoureas

Apoptosis Biochemical events and relevance to cancer chemotherapy

Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti‐cancer agents

p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel

Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis

Decreased cytotoxic effects of doxorubicin in a human ovarian cancer‐cell line expressing wild‐type p53 and WAF1/CIP1 genes

DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin

Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription

Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53

DNA-minor-groove alkylators, a new class of anticancer agents

Selective DNA interaction of the novel distamycin derivative FCE 24517

Clinical pharmacokinetics of altretamine

Importance of the DNA repair enzyme O 6-alkyl guanine alkyltransferase (AT) in cancer chemotherapy

New anticancer agents. state of the art and perspectives

Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase

Suchergebnisse filtern